title: [Somatostatin and SMS 201-995 (octreotide): clinical and therapeutic aspects].
abstract: Nowadays, the digestive system, must be considered as an actual endocrinous gland. The authors, after pointing out the pharmacological and immunomodulating actions of endogenous somatostatine, briefly describe a new synthetic octapeptid, somatostatine-analogue, with similar pharmacological effects (octreotide). Finally they stress the therapeutic trials in which the adverse effects, dosage and administration have been studied.
authors.affiliation: Serviço de Medicina Interna, Hospital de Santa Marta, Lisboa.
authors.forename: P M
authors.initials: PM
authors.lastname: da Silva
authors.forename: F
authors.initials: F
authors.lastname: Augusto
mesh_terms: D006801:Humans; D015282:Octreotide / Q000494:pharmacology / Q000627:therapeutic use*; D013004:Somatostatin / Q000502:physiology*
chemical_list: D013004:Somatostatin; D015282:Octreotide
vernacular_title: Somatostatina e SMS 201-995 (octreótido): aspectos clínicos e terapêuticos.